{"id":189928,"date":"2026-08-07T10:31:05","date_gmt":"2026-08-07T05:01:05","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=189928"},"modified":"2026-08-07T10:31:06","modified_gmt":"2026-08-07T05:01:06","slug":"vijaya-diagnostics-q1-results-fy27-pat-53-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/","title":{"rendered":"Vijaya Diagnostics Q1 FY27 Results: Revenue Rs 230 Cr, PAT Rs 53 Cr and Key Highlights"},"content":{"rendered":"<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Vijaya Diagnostics Q1 FY27 results declared Aug 6, 2026. Revenue Rs 230 Cr (+22.83% YoY). PAT Rs 53 Cr (+37.61% YoY). CMP Rs 1369.8 (-1.42%).<\/em><\/p>\n<p>Vijaya Diagnostics Q1 FY27 results were announced on August 6, 2026, on a Consolidated basis. Vijaya Diagnostics Q1 FY27 results show revenue grew +22.83% year-on-year to Rs 230 Cr from Rs 188 Cr in Q1 FY26, reflecting sustained demand in the Healthcare segment. The broader <a href=\"https:\/\/univest.in\/indices\/bse-hc\/bse-healthcare-share-price-today\">BSE Healthcare<\/a> index also reflected mixed sentiment during the quarter.<\/p>\n<p>Operating profit improved +39.46% YoY to Rs 73 Cr from Rs 52 Cr, indicating stronger operational efficiency. PAT rose +37.61% YoY to Rs 53.00 Cr from Rs 38.00 Cr in Q1 FY26. The quarterly numbers offer a detailed picture of how the company is navigating the current healthcare environment.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=vijaya-diagnostics-q1-fy27\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#Vijaya_Diagnostics_Q1_FY27_Financial_Highlights\" title=\"Vijaya Diagnostics Q1 FY27 Financial Highlights\">Vijaya Diagnostics Q1 FY27 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#Vijaya_Diagnostics_Q1_FY27_Performance_Analysis\" title=\"Vijaya Diagnostics Q1 FY27 Performance Analysis\">Vijaya Diagnostics Q1 FY27 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#Key_Business_Factors_in_Vijaya_Diagnostics_Q1_FY27_Results\" title=\"Key Business Factors in Vijaya Diagnostics Q1 FY27 Results\">Key Business Factors in Vijaya Diagnostics Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#Revenue_Growth_Momentum_in_the_Healthcare_Segment\" title=\"Revenue Growth Momentum in the Healthcare Segment\">Revenue Growth Momentum in the Healthcare Segment<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#Operating_Margin_Expansion_Signals_Efficiency_Gains\" title=\"Operating Margin Expansion Signals Efficiency Gains\">Operating Margin Expansion Signals Efficiency Gains<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#PAT_Performance_and_Profitability_Trend\" title=\"PAT Performance and Profitability Trend\">PAT Performance and Profitability Trend<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#Dividend_Details\" title=\"Dividend Details\">Dividend Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#FY27_Outlook_for_Vijaya_Diagnostics\" title=\"FY27 Outlook for Vijaya Diagnostics\">FY27 Outlook for Vijaya Diagnostics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#Vijaya_Diagnostics_Stock_Performance_After_Q1_FY27_Results\" title=\"Vijaya Diagnostics Stock Performance After Q1 FY27 Results\">Vijaya Diagnostics Stock Performance After Q1 FY27 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#Key_Risks_for_Vijaya_Diagnostics\" title=\"Key Risks for Vijaya Diagnostics\">Key Risks for Vijaya Diagnostics<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#Sector-Specific_Headwinds\" title=\"Sector-Specific Headwinds\">Sector-Specific Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#Valuation_and_Earnings_Risk\" title=\"Valuation and Earnings Risk\">Valuation and Earnings Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#Operational_and_Financial_Risk\" title=\"Operational and Financial Risk\">Operational and Financial Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#Frequently_Asked_Questions_on_Vijaya_Diagnostics_Q1_FY27_Results\" title=\"Frequently Asked Questions on Vijaya Diagnostics Q1 FY27 Results\">Frequently Asked Questions on Vijaya Diagnostics Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#When_were_Vijaya_Diagnostics_Q1_FY27_results_declared\" title=\"When were Vijaya Diagnostics Q1 FY27 results declared?\">When were Vijaya Diagnostics Q1 FY27 results declared?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#What_was_Vijaya_Diagnostics_revenue_in_Q1_FY27\" title=\"What was Vijaya Diagnostics revenue in Q1 FY27?\">What was Vijaya Diagnostics revenue in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#What_was_Vijaya_Diagnostics_PAT_in_Q1_FY27\" title=\"What was Vijaya Diagnostics PAT in Q1 FY27?\">What was Vijaya Diagnostics PAT in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#Did_Vijaya_Diagnostics_declare_a_dividend_in_Q1_FY27\" title=\"Did Vijaya Diagnostics declare a dividend in Q1 FY27?\">Did Vijaya Diagnostics declare a dividend in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#What_is_the_FY27_outlook_for_Vijaya_Diagnostics\" title=\"What is the FY27 outlook for Vijaya Diagnostics?\">What is the FY27 outlook for Vijaya Diagnostics?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/vijaya-diagnostics-q1-results-fy27-pat-53-crore\/#How_did_the_Vijaya_Diagnostics_stock_react_to_Q1_FY27_results\" title=\"How did the Vijaya Diagnostics stock react to Q1 FY27 results?\">How did the Vijaya Diagnostics stock react to Q1 FY27 results?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Vijaya_Diagnostics_Q1_FY27_Financial_Highlights\"><\/span><strong>Vijaya Diagnostics Q1 FY27 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse; font-size: 14px;\">\n<thead>\n<tr style=\"background: #0A0E1A; color: #ffffff;\">\n<th style=\"padding: 10px; text-align: left; border: 1px solid #DDDDDD;\">Metric<\/th>\n<th style=\"padding: 10px; text-align: center; border: 1px solid #DDDDDD;\">Q1 FY27 (Rs Cr)<\/th>\n<th style=\"padding: 10px; text-align: center; border: 1px solid #DDDDDD;\">Q1 FY26 (Rs Cr)<\/th>\n<th style=\"padding: 10px; text-align: center; border: 1px solid #DDDDDD;\">YoY Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 8px; border: 1px solid #DDDDDD;\">Vijaya Diagnostics Revenue<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDDDDD;\">230<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDDDDD;\">188<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDDDDD; color: green;\">+22.83%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border: 1px solid #DDDDDD;\">Operating Profit<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDDDDD;\">73<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDDDDD;\">52<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDDDDD; color: green;\">+39.46%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border: 1px solid #DDDDDD;\">Net Profit (PAT)<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDDDDD;\">53<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDDDDD;\">38<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDDDDD; color: green;\">+37.61%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border: 1px solid #DDDDDD;\">Reporting Basis<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDDDDD;\" colspan=\"3\">Consolidated<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Vijaya_Diagnostics_Q1_FY27_Performance_Analysis\"><\/span><strong>Vijaya Diagnostics Q1 FY27 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for Live Data on This Stock<\/strong><\/a><\/p>\n<p>Vijaya Diagnostics Q1 FY27 results reflect healthy fundamentals across key financial parameters. Revenue momentum continued on a strong footing with the top line reaching Rs 230 Cr for the April to June 2026 quarter.<\/p>\n<p>Operating profit stood at Rs 73 Cr, expanding +39.46% YoY. Margin improvement signals better cost absorption and product mix optimisation.<\/p>\n<p>PAT of Rs 53 Cr marks a +37.61% year-on-year improvement. Investors monitoring Vijaya Diagnostics Q1 FY27 results will note this as a key milestone for FY27 tracking.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_in_Vijaya_Diagnostics_Q1_FY27_Results\"><\/span><strong>Key Business Factors in Vijaya Diagnostics Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_Growth_Momentum_in_the_Healthcare_Segment\"><\/span><strong>Revenue Growth Momentum in the Healthcare Segment<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Vijaya Diagnostics Q1 FY27 results demonstrate consistent top-line expansion, with revenue rising +22.83% YoY to Rs 230 Cr. Volume-led growth and pricing discipline in key markets drove the uptick.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Operating_Margin_Expansion_Signals_Efficiency_Gains\"><\/span><strong>Operating Margin Expansion Signals Efficiency Gains<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Operating profit in Vijaya Diagnostics Q1 FY27 results rose +39.46% YoY to Rs 73 Cr. This reflects tighter cost control, better product mix, and operating leverage as the company scales volumes in core business lines.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"PAT_Performance_and_Profitability_Trend\"><\/span><strong>PAT Performance and Profitability Trend<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Net profit in Vijaya Diagnostics Q1 FY27 results stood at Rs 53 Cr (+37.61% YoY). The sustained PAT growth reflects the company&#8217;s improving financial profile.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dividend_Details\"><\/span><strong>Dividend Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No dividend was announced along with Vijaya Diagnostics Q1 FY27 results. The company is likely retaining earnings for reinvestment into growth capex and working capital requirements.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook_for_Vijaya_Diagnostics\"><\/span><strong>FY27 Outlook for Vijaya Diagnostics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Vijaya Diagnostics is positioned to maintain growth momentum into Q2 FY27 and beyond, supported by order visibility, operational improvements, and sector tailwinds. Management guidance points toward continued expansion in the Healthcare business with a focus on margin improvement and market share consolidation. Investors tracking Vijaya Diagnostics Q1 FY27 results are advised to consult a SEBI-registered financial advisor before making decisions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Vijaya_Diagnostics_Stock_Performance_After_Q1_FY27_Results\"><\/span><strong>Vijaya Diagnostics Stock Performance After Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Vijaya Diagnostics live price and get daily stock recommendations.<\/em><\/p>\n<p>Vijaya Diagnostics shares were trading lower at Rs 1369.8 (-1.42%) on August 6, 2026, following the declaration of Vijaya Diagnostics Q1 FY27 results. The stock reaction reflects investor sentiment on near-term earnings trajectory and sector outlook. CMP stood at Rs 1369.8 on the results date, with a 52-week range reflecting the broader market sentiment toward the healthcare sector.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_for_Vijaya_Diagnostics\"><\/span><strong>Key Risks for Vijaya Diagnostics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Sector-Specific_Headwinds\"><\/span><strong>Sector-Specific Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Rising operational costs, competition from hospital chains, and insurance penetration risks could limit upside.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_and_Earnings_Risk\"><\/span><strong>Valuation and Earnings Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Valuation risk remains if earnings growth fails to sustain at current levels over the next two to three quarters.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Operational_and_Financial_Risk\"><\/span><strong>Operational and Financial Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Subsidiary-level losses or underperformance in overseas operations could drag consolidated PAT lower.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Vijaya Diagnostics Q1 FY27 results demonstrate healthy financial performance with revenue at Rs 230 Cr and PAT at Rs 53 Cr on a Consolidated basis. Operating leverage and disciplined cost management will be key drivers for the rest of FY27. Investors should track upcoming management commentary on growth drivers and sector developments before taking positions.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Vijaya_Diagnostics_Q1_FY27_Results\"><\/span><strong>Frequently Asked Questions on Vijaya Diagnostics Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"When_were_Vijaya_Diagnostics_Q1_FY27_results_declared\"><\/span><strong>When were Vijaya Diagnostics Q1 FY27 results declared?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Vijaya Diagnostics Q1 FY27 results were declared on August 6, 2026. The results cover the April to June 2026 quarter on a Consolidated basis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Vijaya_Diagnostics_revenue_in_Q1_FY27\"><\/span><strong>What was Vijaya Diagnostics revenue in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Vijaya Diagnostics Q1 FY27 results show revenue of Rs 230 Cr, +22.83% compared to Rs 188 Cr in Q1 FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Vijaya_Diagnostics_PAT_in_Q1_FY27\"><\/span><strong>What was Vijaya Diagnostics PAT in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Net profit (PAT) in Vijaya Diagnostics Q1 FY27 results was Rs 53 Cr, +37.61% year-on-year.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Vijaya_Diagnostics_declare_a_dividend_in_Q1_FY27\"><\/span><strong>Did Vijaya Diagnostics declare a dividend in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No dividend was declared alongside Vijaya Diagnostics Q1 FY27 results. Investors should check the official company announcements on BSE and NSE for any future dividend declarations.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_FY27_outlook_for_Vijaya_Diagnostics\"><\/span><strong>What is the FY27 outlook for Vijaya Diagnostics?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Vijaya Diagnostics management has outlined a focus on revenue scaling and margin improvement for the remainder of FY27. Sector tailwinds and order book visibility will be key monitorables.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_the_Vijaya_Diagnostics_stock_react_to_Q1_FY27_results\"><\/span><strong>How did the Vijaya Diagnostics stock react to Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Vijaya Diagnostics shares were trading lower at Rs 1369.8 (-1.42%) on August 6, 2026, following the Vijaya Diagnostics Q1 FY27 results announcement. Investors should consult a SEBI-registered financial advisor before acting on price movements.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vijaya Diagnostics Q1 FY27 results: Revenue Rs 230 Cr (+22.83% YoY), PAT Rs 53 Cr (+37.61% YoY). Key highlights, financial analysis and FY27 outlook.<\/p>\n","protected":false},"author":35,"featured_media":189927,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-189928","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["189927"],"_edit_lock":["1786078870:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["74"],"rank_math_title":["Vijaya Diagnostics Q1 FY27 Results: Revenue, PAT &amp; Key Highlights"],"rank_math_description":["Vijaya Diagnostics Q1 FY27 results: Revenue Rs 230 Cr (+22.83% YoY), PAT Rs 53 Cr (+37.61% YoY). Key highlights, financial analysis and FY27 outlook."],"rank_math_focus_keyword":["Vijaya Diagnostics Q1 FY27 results"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["34775"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/vijaya-diagnostics-q1-results-fy27-pat-53-crore.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/189928","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=189928"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/189928\/revisions"}],"predecessor-version":[{"id":189965,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/189928\/revisions\/189965"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/189927"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=189928"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=189928"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=189928"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}